Tenet Healthcare Corp (THC) stock
THCNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3036% below fair value
$286.86−6.11 (-2.09%)
Close on Nov 12, 2026Market cap $22.83BP/E 8.3Yield –
Tenet Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Tenet Healthcare's ebitda for the twelve months ending Sep 30, 2026 was $6.29B, up 46.3% year over year. For fiscal 2025 it was $4.37B, down 35.5% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $6.77B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.37B | -35.5% |
| FY2024 | Dec 31, 2024 | $6.77B | +100.4% |
| FY2023 | Dec 31, 2023 | $3.38B | +6.5% |
| FY2022 | Dec 31, 2022 | $3.17B | -14.8% |
| FY2021 | Dec 31, 2021 | $3.73B | +30.9% |
| FY2020 | Dec 31, 2020 | $2.85B | +19.2% |
| FY2019 | Dec 31, 2019 | $2.39B | -2.1% |
| FY2018 | Dec 31, 2018 | $2.44B | +23.0% |
| FY2017 | Dec 31, 2017 | $1.98B | -5.4% |
| FY2016 | Dec 31, 2016 | $2.10B | +11.9% |
| FY2015 | Dec 31, 2015 | $1.87B | +5.6% |
| FY2014 | Dec 31, 2014 | $1.77B | +46.9% |
| FY2013 | Dec 31, 2013 | $1.21B | +2.5% |
| FY2012 | Dec 31, 2012 | $1.18B | +12.2% |
| FY2011 | Dec 31, 2011 | $1.05B | +3.6% |
| FY2010 | Dec 31, 2010 | $1.01B | +9.7% |
| FY2009 | Dec 31, 2009 | $924.00M | +35.5% |
| FY2008 | Dec 31, 2008 | $682.00M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.97B | +77.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.72B | +66.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.53B | +32.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.08B | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.11B | -14.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.03B | +6.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.15B | -67.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.01B | +6.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.30B | +63.9% |
| Q2 FY2024 | Jun 30, 2024 | $969.00M | +18.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.49B | +326.0% |
| Q4 FY2023 | Dec 31, 2023 | $951.00M | +27.0% |
| Q3 FY2023 | Sep 30, 2023 | $792.00M | -1.6% |
| Q2 FY2023 | Jun 30, 2023 | $817.00M | +6.2% |
| Q1 FY2023 | Mar 31, 2023 | $820.00M | -3.6% |
| Q4 FY2022 | Dec 31, 2022 | $749.00M | -21.3% |
| Q3 FY2022 | Sep 30, 2022 | $805.00M | -34.2% |
| Q2 FY2022 | Jun 30, 2022 | $769.00M | -4.7% |
| Q1 FY2022 | Mar 31, 2022 | $851.00M | +14.4% |
| Q4 FY2021 | Dec 31, 2021 | $952.00M | -17.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.22B | +151.6% |
| Q2 FY2021 | Jun 30, 2021 | $807.00M | +19.2% |
| Q1 FY2021 | Mar 31, 2021 | $744.00M | +40.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.15B | +70.3% |
| Q3 FY2020 | Sep 30, 2020 | $486.00M | -4.1% |
| Q2 FY2020 | Jun 30, 2020 | $677.00M | +10.3% |
| Q1 FY2020 | Mar 31, 2020 | $530.00M | -10.0% |
| Q4 FY2019 | Dec 31, 2019 | $677.00M | +14.0% |
| Q3 FY2019 | Sep 30, 2019 | $507.00M | -3.2% |
| Q2 FY2019 | Jun 30, 2019 | $614.00M | +2.3% |
| Q1 FY2019 | Mar 31, 2019 | $589.00M | -18.3% |
| Q4 FY2018 | Dec 31, 2018 | $594.00M | -14.3% |
| Q3 FY2018 | Sep 30, 2018 | $524.00M | +94.1% |
| Q2 FY2018 | Jun 30, 2018 | $600.00M | +12.8% |
| Q1 FY2018 | Mar 31, 2018 | $721.00M | +47.7% |
| Q4 FY2017 | Dec 31, 2017 | $693.00M | +39.2% |
| Q3 FY2017 | Sep 30, 2017 | $270.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $532.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $488.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $498.00M | – |
See a number that looks wrong?